Skip to content
  • Grants
    • International Grants
    • US Grants
  • Tools
    • Patient Registry
  • Archive
    • Case Studies
    • GPRO
      • List of HBV Access Countries
      • List of HCV Access Countries
    • Reports
    • UHEP
      • Overview
      • Coalition of Partners
      • Project Team
      • Innovations and Optimizations
      • Methodology
      • Disease Burden and Financials
      • UHEP Data – March 2020
      • UHEP Data – Final
    • US State Analyses
      • States Dashboard
      • States Compare
      • States Maps
      • States Distribution
      • Donors
  • Contact
  • Donate
  • Privacy Statement
  • CDA Foundation
  • CDAF
    • Overview
    • Board of Directors
    • Corporate Documents
    • Our Team
    • Publications
    • In the News
    • Conference Proceedings
  • Polaris
    • Overview
    • Dashboard
    • Compare
    • Elimination Maps
    • Global Distribution
    • Database Query
    • FAQ
    • Training
    • Donors
    • Collaborator Portal
  • Relink
    • Overview
    • FAQ
    • Request for Proposal
    • Grantees
    • Hep-CARE
    • Resources
  • CDAF
    • Overview
    • Board of Directors
    • Corporate Documents
    • Our Team
    • Publications
    • In the News
    • Conference Proceedings
  • Polaris
    • Overview
    • Dashboard
    • Compare
    • Elimination Maps
    • Global Distribution
    • Database Query
    • FAQ
    • Training
    • Donors
    • Collaborator Portal
  • Relink
    • Overview
    • FAQ
    • Request for Proposal
    • Grantees
    • Hep-CARE
    • Resources
  • Grants
    • International Grants
    • US Grants
  • Tools
    • Patient Registry
  • Archive
    • Case Studies
    • GPRO
      • List of HBV Access Countries
      • List of HCV Access Countries
    • Reports
    • UHEP
      • Overview
      • Coalition of Partners
      • Project Team
      • Innovations and Optimizations
      • Methodology
      • Disease Burden and Financials
      • UHEP Data – March 2020
      • UHEP Data – Final
    • US State Analyses
      • States Dashboard
      • States Compare
      • States Maps
      • States Distribution
      • Donors
  • Contact
  • Donate
  • Privacy Statement
  • Polaris

    Compare

    Overview

    Dashboard

    Compare

    Elimination Maps

    Migration Analysis

    Global Distribution

    Database Query

    FAQ

    Training

    Donors

    Collaborator Portal

    Example Citation: The CDA Foundation. Hepatitis C – [Country name]. Lafayette, CO: CDA Foundation, 2025. Available from https://cdafound.org/polaris/database-query/ (Accessed [INSERT DATE])

    Acronyms
    3+ Dose
    Three or more doses of HBV vaccine
    HBIG
    Hepatitis B immunoglobulin
    Tx
    Treated
    PWID
    People who inject drugs
    N/A
    Not applicable
    ND, -
    No data

    The above prevalence, diagnosed, treated and mortality estimates are based on published data.  These numbers have been updated with the most recent data.  Forecasts for 2023–2030 are available, free of charge, to national hepatitis programs and collaborators upon request (requestdata@cdafound.org).

    Flag icons for countries/territories used with permission from the Twemoji library v16.0.1

    Terms & Conditions

    1120W South Boulder Rd
    Suite 102
    Lafayette, CO 80026


    • Phone: 720.890.4848
    • Fax: 720.890.3817
    • Email: info@cdafound.org

    Useful Links, CDAF

    • Overview
    • Board of Directors
    • Publications
    • Conference Proceedings

    Useful Links, Polaris

    • Overview
    • FAQ
    • Training
    • Collaborator Portal

    Latest News

    Center for Disease Analysis Foundation Awards Second Round of Grants for the CDAF-Relink Program

    July 30, 2024

    Read More

    Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant

    March 18, 2024

    Read More
    USFCR Verified Vendor

    Copyright ©2025 CDA Foundation

    Copyright ©2025 CDA Foundation

    en_USEnglish
    es_MXSpanish fr_FRFrench ru_RURussian arArabic en_USEnglish
    Manage Cookie Consent
    We use cookies to optimize our website and our service.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    Preferences
    {title} {title} {title}